Mogamulizumab-kpkc Intravenous and Treprostinil Extended-Release Tablets
Determining the interaction of Mogamulizumab-kpkc Intravenous and Treprostinil Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: treprostinil
Brand name: Orenitram, Remodulin, Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit
Synonyms: Treprostinil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Treprostinil inhalation
- Mogamulizumab-kpkc Intravenous-Treprostinil injection
- Mogamulizumab-kpkc Intravenous-Treprostinil Injection Solution
- Mogamulizumab-kpkc Intravenous-Treprostinil Oral Inhalation Solution
- Mogamulizumab-kpkc Intravenous-Treprostinil Sodium
- Mogamulizumab-kpkc Intravenous-Tresiba
- Treprostinil Extended-Release Tablets-Molindone
- Treprostinil Extended-Release Tablets-Mometasone (Oral Inhalation)
- Treprostinil Extended-Release Tablets-Mometasone and Formoterol
- Treprostinil Extended-Release Tablets-Mometasone and formoterol Inhalation
- Treprostinil Extended-Release Tablets-Mometasone Cream
- Treprostinil Extended-Release Tablets-Mometasone Furoate